Morphea Scleroderma PDF Print E-mail
Wednesday, 09 December 2009 14:48
taken from http://dermnetnz.org/immune/img/morph2-s.jpgMorphea, is one of two types of localized Scleroderma, and a disorder characterized by excessive collagen deposits leading to thickening of the dermis, subcutaneous tissues, or both. The cause of Scleroderma is unknown. It is important to remember that it is not contagious, nor inherited or passed on from one generation to the next, except in rare circumstances. We do know that in Scleroderma, the body produces too much of a protein called collagen.

Morphea is classified into plaque, generalized, linear, and deep subtypes according to the clinical presentation and depth of tissue involvement.

Unlike Systemic Sclerosis, Morphea lacks features such as Sclerodactyly, Raynaud's phenomenon, and internal organ involvement. Saleh et al (2009) discussed a new variant, termed Superficial Morphea, which is characterized clinically by hyperpigmented or hypopigmented patches of skin that lack induration.

taken from http://www.lib.uiowa.edu/HARDIN/MD/pictures22/dermnet/morphea61.jpgEarly Morphea Scleroderma has an inflammatory stage, followed by one or more slowly enlarging patches or plaques. These plaques are most commonly oval in shape and vary in size. They have an ivory/yellow center and are surrounded by a violet colored area.

The violet color signifies that the Scleroderma is in a state of activity. The plaques feel firm and hard, but are not deeply bound down. They may be depressed or slightly elevated and are seen more often on the trunk, but may also occur on the face and extremities.

An uncommon form of Morphea is the guttate variety. It is characterized by multiple, small, chalk-white spots which vary in size from 1 to 10mm in diameter. The violet-colored line may surround all or some of the spots and in cases of long duration the line may be brown or grayish. Guttate Morphea primarily involves the chest, neck and shoulders, and only occasionally other parts of the body. Localized Morphea may last from a few months to many years. However, a large proportion of Morphea patients improve spontaneously.

The following are some excellent resources, which have additional information and images on Morphea Scleroderma. You can  read more about treatments, types, and associated complications.

HealthCentral.com (2009), "Morphea Scleroderma". http://www.healthcentral.com/encyclopedia/408/37.html
HealthScout (2009), "Morphea Scleroderma". http://www.healthscout.com/ency/68/37/main.html
EMedicine (2009), "Morphea". http://emedicine.medscape.com/article/1065782-overview
AOCD (2009), "Morphea". http://www.aocd.org/skin/dermatologic_diseases/morphea.html
MayoClinic (2009), "Morphea". http://www.mayoclinic.com/health/morphea/DS00718/DSECTION=symptoms

 
More articles :

» DETECT Algorithm Increases Rate Of Diagnosis For PAH In Scleroderma Patients

The use of a two-step algorithm significantly increased the rate at which pulmonary arterial hypertension was diagnosed in patients with in a prospective, observational, cross-sectional study. The results of the , presented at the annual European...

» Capillaroscopy, Autoantibody Findings Predict Raynaud's Progression

Abnormal findings on nailfold and the presence of scleroderma-specific autoantibodies in patients presenting with new-onset without overt connective tissue disease are powerful independent predictors of progression to definite .A landmark Canadian...

» Anticoagulation of Systemic Sclerosis Patients In Question

Australia is in a state of ‘clinical equipoise’ over whether to anticoagulate systemic sclerosis patients with pulmonary hypertension, experts say. And with observational studies showing the treatment is associated with a  fivefold...

» What's Your Scleroderma Action Plan?

Living with any serious disease or condition like Scleroderma, is without a doubt, difficult. It is not hard to understand either, that we often can lose sight of what is important, including our way. We may also fall into to a false sense of...

» The Clinical Relevance of Autoantibodies in Scleroderma

Khanh T Ho and John D ReveillePublished: 12 February 2003Arthritis Res Ther 2003, 5:80-93 (DOI 10.1186/ar628)© 2003 BioMed Central Ltd (Print ISSN 1478-6354; Online ISSN 1478-6362)Scleroderma (systemic sclerosis) is associated with several...

» Rare Diseases Day

Febuary 28th, 2010 was Rare Diseases Day, and it was marked with a variety of events and activities all over the world - as well as with plenty of citizen media and online participation. The goal was to raise awareness about so-called. These are...